Stock Earnings

Question 1

Quels sont les états financiers clés de Acura Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Acura Pharmaceuticals Inc a un total d'actifs de $0, un bénéfice net loss de $0

Question 2

Quels sont les ratios financiers clés pour ACUR ?

Accepted Answer

Le ratio de liquidité de Acura Pharmaceuticals Inc est 0, la marge nette est 0, les ventes par action sont de $0.01.

Question 3

Comment les revenus de Acura Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Acura Pharmaceuticals Inc data is not available.

Question 4

Acura Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Acura Pharmaceuticals Inc a un bénéfice net loss de $0

Question 5

Acura Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

no, Acura Pharmaceuticals Inc a un passif de 0

Question 6

Combien d'actions en circulation Acura Pharmaceuticals Inc a-t-elle ?

Accepted Answer

Acura Pharmaceuticals Inc a un total d'actions en circulation de 65.09

Breakdown	TTM	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Revenue	1	1	3	2	0	2
Revenue Growth (YoY)	-67%	-67%	50%	--	-100%	-50%
Cost of Revenue	--	--	--	--	0	0
Gross Profit	--	--	--	--	0	2
Selling, General & Admin	1	1	2	1	2	4
Research & Development	1	1	1	1	1	3
Operating Expenses	2	2	4	3	4	8
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	0	0	-1	-3	-3	-5
Income Tax Expense	0	0	0	0	0	-26
Net Income	0	0	-1	-3	-3	-5
Net Income Growth	-100%	-100%	-67%	0%	-40%	-28.99%
Shares Outstanding (Diluted)	75.81	56.8	32.32	26.72	21.14	15.9
Shares Change (YoY)	134%	76%	21%	26%	33%	34%
EPS (Diluted)	-0.02	-0.01	-0.03	-0.14	-0.18	-0.35
EPS Growth	-52%	-59%	-74%	-22%	-48%	-44%
Free Cash Flow	0	0	0	0	-3	-4
Free Cash Flow Per Share	0	0	0	0	-0.14	-0.25
Gross Margin	--	--	--	--	0%	100%
Operating Margin	-100%	-100%	0%	0%	0%	-250%
Profit Margin	0%	0%	-33.33%	-150%	0%	-250%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-200%
EBITDA	-1	-1	0	0	-3	-5
EBITDA Margin	-100%	-100%	0%	0%	0%	-250%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-1	-1	0	0	-3	-5
EBIT Margin	-100%	-100%	0%	0%	0%	-250%
Effective Tax Rate	0%	0%	0%	0%	0%	520%

Acura Pharmaceuticals Inc (ACUR) Price